CStone Pharmaceuticals (HKG:2616)

CStone Pharmaceuticals Revenue

CStone Pharmaceuticals had revenue of 49.45M CNY in the half year ending June 30, 2025, a decrease of -81.09%. This brings the company's revenue in the last twelve months to 202.49M, down -55.65% year-over-year. In the year 2024, CStone Pharmaceuticals had annual revenue of 407.21M, down -12.21%.

• Revenue (ttm): 202.49M CNY
• Revenue Growth: -55.65%
• P/S Ratio: 36.36
• Revenue / Employee: 1.55M CNY
• Employees: 131
• Market Cap: 8.07B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	407.21M	-56.64M	-12.21%
Dec 31, 2023	463.84M	-17.52M	-3.64%
Dec 31, 2022	481.36M	237.65M	97.51%
Dec 31, 2021	243.72M	-795.11M	-76.54%
Dec 31, 2020	1.04B	-	-